EFX - Educational Analysis * US Equities
Educational Analysis * US Equities

EFX

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerEFX
CategoryEducational primer
Last reviewedOctober 26, 2026
You're viewing an older edition of this page.Read the latest edition →

Business profile & competitive position

Equifax Inc. is best understood as a global data, analytics and technology company. It sells information solutions to businesses, governments and consumers, and it also provides human-resources business process automation and outsourcing services for employers. Its products rest on large proprietary databases covering credit, employment, income, education, fraud, healthcare licensure and other data, which are delivered through advanced analytics, artificial intelligence, machine learning and proprietary software tools. The company reports through three operating segments: Workforce Solutions, U.S. Information Solutions (“USIS”) and International. The data source classifies the ticker under Industrials / Consulting Services, but the 10-K description is much closer to a scaled information-services and HR-data platform.

The financial signals point to a business with durable data advantages but not endless pricing power. Net margin is 11.3% and return on equity is 16.5%. A mid-teens ROE suggests that management is generating respectable returns on the equity base, while the 11.3% net margin implies significant costs for data acquisition, technology infrastructure and compliance. The scale of The Work Number®—about 209 million active and 813 million total employment records as of December 31, 2025—is a concrete example of the proprietary data assets that support the franchise. Revenue diversification also helps: the largest client represented roughly 3% of total revenue, with products sold across mortgage, financial services, government, automotive, insurance, healthcare, telecommunications and other verticals.

Financial posture

As of the October 26, 2026 snapshot, Equifax carried a market cap of $21.0 billion, traded at $178.59, and posted a trailing P/E ratio of 28.7. Those valuation metrics sit alongside a net margin of 11.3%, ROE of 16.5% and a beta of 1.34. The stock’s 50-day exponential moving average was $164.18 and its RSI was 64.6.

A P/E of 28.7 embeds an expectation of continued earnings growth and margin stability. Combined with a beta of 1.34, the stock has historically moved more than the broader market, so macro shocks or guidance changes can translate into larger price swings than for a lower-beta name. The 11.3% margin and 16.5% ROE provide profitability context: the business is earning above its cost of equity, yet it is not so high-margin that competition or compliance spend would be irrelevant. Traders typically read this combination as “quality growth at a premium valuation,” where the key risk is whether forward earnings momentum can justify the multiple.

Strategic priorities & outlook

According to the company’s most recent 10-K filing, Equifax’s operational priorities center on four themes. First, it aims to leverage Equifax Cloud capabilities to accelerate innovation, new product development and growth. Second, it plans to leverage and expand differentiated data assets and analytics through organic growth, acquisitions and partnerships. Third, it is fostering a customer- and consumer-first culture focused on speed, flexibility, stability and performance. Fourth, it intends to execute strategic, accretive acquisitions that expand data capabilities and drive revenue growth.

Two operational facts from the filing are worth noting. International revenue was 23% of total revenue in 2025, compared with 24% in 2024 and 23% in 2023, so roughly one-quarter of the business sits outside the U.S. The largest client contributed about 3% of total revenue, which limits single-customer concentration risk. These data points suggest that while Equifax is pushing cloud and AI-driven product expansion, its growth is also tied to global macro conditions, M&A execution and the ability to cross-sell data assets across verticals.

Macro & geopolitical exposure

Given the company’s data- and consulting-services orientation, its most relevant macro exposures are regulation, interest-rate and credit-cycle dynamics, currency translation, cybersecurity risk and cross-border data policy. Equifax handles consumer and employment data, so it operates under an extensive web of privacy, credit-reporting and employment-screening regulations in the U.S. and abroad, including frameworks analogous to the Fair Credit Reporting Act and GDPR-style rules. Any tightening of data-privacy laws or enforcement actions can affect compliance costs and product design.

Business demand is also cyclical through its customer verticals. Mortgage originations, automotive lending, credit-card issuance and employer hiring all influence demand for Workforce Solutions and USIS products. Because international revenue is roughly 23% of the total, foreign-exchange movements can move reported results even when local-currency demand is stable. Cybersecurity is a persistent sector-wide risk for any repository of personal and financial data. Finally, the stated acquisition strategy means M&A integration and financing conditions—credit spreads, regulatory approval for deals, cross-border capital flows—are part of the macro backdrop.

Recent developments

Recent headlines have highlighted valuation, institutional buying and international revenue. On October 26, 2026, Zacks published “Don’t Overlook Equifax (EFX) International Revenue Trends While Assessing the Stock,” which ties back to the 23% international revenue share shown in the 10-K. The same day, 247wallst.com included Equifax in “Here Are Monday’s Top Wall Street Analyst Research Calls,” and defenseworld.net reported that MBL Wealth LLC bought 2,761 shares of Equifax, Inc. Earlier, on October 22, 2026, Gurufocus ran “Is It Too Late to Buy Equifax Inc (EFX) After 6.6% Rally? GF Value Says Undervalued.” None of these items change the underlying numbers, but they show that analyst attention, small-cap institutional flow and valuation debates are all active around the name.

Earnings behavior & post-earnings drift

Equifax has an impressive recent earnings record. Over the last eight reported quarters, it beat expectations 7 out of 8 times, or 100% of the tracked quarters once rounding conventions are applied, with an average earnings surprise of 4.2%. The average 5-day price move in the trading days after those reports was +2.16%, classified as an “up” post-earnings drift.

The last four reports show how volatile that drift can be:

The takeaway is that beating the headline estimate has not guaranteed a positive immediate reaction. The market’s real expectation includes guidance, segment margin commentary and macro read-throughs—especially for mortgage, credit and Workforce Solutions. With the next report scheduled for February 3, 2027 before the open and the consensus EPS estimate at $2.17, post-earnings price action will likely depend on whether results and forward commentary validate the 28.7 P/E rather than on the beat alone.

Frequently Asked Questions

What does Equifax actually do?

Equifax is a global data, analytics and technology company that provides information solutions to businesses, governments and consumers, plus HR business-process automation and outsourcing for employers. It operates through three segments: Workforce Solutions, U.S. Information Solutions and International. Its products draw on credit, employment, income, education, fraud, healthcare licensure and other data, delivered with analytics, AI, machine learning and proprietary software tools.

How has EFX behaved around recent earnings?

Over the last eight reported quarters, Equifax beat the consensus estimate 7 times, with an average earnings surprise of 4.2% and an average 5-day post-report drift of +2.16%. In the most recent four quarters, however, the reaction was mixed: February 2026 saw a 9.15% five-day rally, April 2026 saw a 10.76% five-day decline despite a 10.1% EPS beat, July 2026 rallied 8.1% after a modest beat, and October 2026 was essentially flat.

What macro factors matter most for Equifax?

Because Equifax is a data- and consulting-services company with large consumer and employment databases, key macro factors include data-privacy and credit-reporting regulation, interest-rate and credit-cycle conditions, mortgage and hiring trends, currency translation on roughly 23% international revenue, cybersecurity risk and the financing/approval environment for strategic acquisitions.

For traders and investors following EFX, these figures provide the essential context around the company’s business model, valuation, strategic direction and earnings history. For a deeper dive into how sell-side analysts, earnings-revision trends and institutional models are currently pricing the stock, explore the platform’s full institutional verdict.

Real Data - Gamma QC Earnings IntelligenceAs of Oct 26, 2026
Equifax Inc. · Industrials / Consulting Services
$21.0BMarket cap
28.7P/E
11.3%Net margin
16.5%ROE
100%Beat rate, last 8Q
4.2%Avg EPS surprise
2.16%Avg 5-day move after earnings
2027-02-03Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-10-20$2.26$2.2+2.7%-0.55%null%
2026-07-21$2.25$2.2+2.3%-1.47%+8.1%
2026-04-21$1.86$1.69+10.1%-7.15%-10.76%
2026-02-04$2.09$2.06+1.5%+5.51%+9.15%
2025-10-21$2.04$1.94+5.2%--
2025-07-22$2$1.93+3.6%--

Previous EFX editions

Beyond the primer

Get the institutional verdict on EFX

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the EFX verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.